ACTINIUM PHARMACEUTICALS, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Jun 2011 | $0 | — | — |
| Sep 2011 | $0 | $-2.4K | $-3.5K |
| Dec 2011 | $0 | $-2.7K | $-4.0K |
| Mar 2012 | $0 | $-1.0M | $-908.9K |
| Jun 2012 | $0 | $-839.3K | $-1.6M |
| Sep 2012 | $0 | $-2.4M | $-3.0M |
| Mar 2013 | — | $-2.0M | $-689.0K |
| Jun 2013 | — | $-1.5M | $-2.8M |
| Sep 2013 | — | $-1.6M | $-1.4M |
| Mar 2014 | — | $-4.1M | $-16.7M |
| Jun 2014 | — | $-4.4M | $3.5M |
| Sep 2014 | — | $-7.0M | $-6.1M |
| Mar 2015 | — | $-7.9M | $-3.1M |
| Jun 2015 | — | $-7.4M | $-7.5M |
| Sep 2015 | — | $-4.6M | $-3.9M |
| Mar 2016 | — | $-6.0M | $-4.4M |
| Jun 2016 | — | $-6.9M | $-6.6M |
| Sep 2016 | — | $-7.1M | $-6.6M |
| Mar 2017 | — | $-7.8M | $-8.1M |
| Jun 2017 | — | $-7.2M | $-7.1M |
| Sep 2017 | — | $-6.7M | $-6.3M |
| Mar 2018 | — | $-6.4M | $-6.3M |
| Jun 2018 | — | $-4.9M | $-4.9M |
| Sep 2018 | — | $-6.2M | $-6.1M |
| Mar 2019 | — | $-5.7M | $-5.7M |
| Jun 2019 | — | $-5.1M | $-5.0M |
| Sep 2019 | — | $-6.7M | $-6.6M |
| Mar 2020 | — | $-5.7M | $-5.7M |
| Jun 2020 | — | $-4.7M | $-4.6M |
| Sep 2020 | — | $-5.6M | $-5.5M |
| Mar 2021 | $622.0K | $-5.4M | $-5.3M |
| Jun 2021 | $266.0K | $-5.1M | $-5.0M |
| Sep 2021 | $233.0K | $-6.5M | $-6.4M |
| Mar 2022 | $940.0K | $-5.2M | $-5.1M |
| Jun 2022 | $45.0K | $-7.9M | $-7.8M |
| Sep 2022 | $45.0K | $-9.8M | $-9.5M |
| Mar 2023 | — | $-11.6M | $-11.0M |
| Jun 2023 | — | $-15.6M | $-15.2M |
| Sep 2023 | — | $-14.4M | $-13.3M |
| Mar 2024 | — | $-9.6M | $-8.7M |
| Jun 2024 | — | $-12.4M | $-11.4M |
| Sep 2024 | — | $-12.6M | $-11.6M |
| Mar 2025 | — | $-16.6M | $-15.9M |
| Jun 2025 | — | $-7.5M | $-6.9M |
| Sep 2025 | $90.0K | $-5.7M | $-5.1M |
| Mar 2026 | — | $-5.9M | $-5.5M |
| Jun 2026 | $35.0M | $27.6M | $27.9M |